Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals
Abstract The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing pattern of HBV infection in a former hyperendemic area (Afragola, South Italy), and to assess the long-term persistence of anti-HBs in two cohorts of individuals vaccinated as infants 18 and 23 yea...
Gespeichert in:
| Veröffentlicht in: | Vaccine 2007-04, Vol.25 (16), p.3133-3136 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3136 |
|---|---|
| container_issue | 16 |
| container_start_page | 3133 |
| container_title | Vaccine |
| container_volume | 25 |
| creator | Da Villa, Giuliano Romanò, Luisa Sepe, Alessio Iorio, Raffaele Paribello, Nunzio Zappa, Alessandra Zanetti, Alessandro R |
| description | Abstract The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing pattern of HBV infection in a former hyperendemic area (Afragola, South Italy), and to assess the long-term persistence of anti-HBs in two cohorts of individuals vaccinated as infants 18 and 23 years ago. Our data shows a significant decline in the prevalence of hepatitis B virus (HBV) markers in the general population from 1978 to 2006 (HBsAg: 13.4% versus 0.91%; anti-HBc: 66.9% versus 7.6%; p < 0.001). Data from two cohorts of vaccinees provides further evidence regarding the long-term persistence of vaccine-induced anti-HBs. Data here reported indicates that the implementation of vaccination had a great impact in the control and prevention of hepatitis B in Italy. |
| doi_str_mv | 10.1016/j.vaccine.2007.01.044 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70331992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X0700062X</els_id><sourcerecordid>20313564</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-81b2283beebd53742a2f7883954df863376fd3ba30f8e932188f58374ca4335e3</originalsourceid><addsrcrecordid>eNqFks9u1DAQxiMEotvCI4AsIbhl8Z84cS4gWgFdqRIHQOrNcuxJ10tiL7azaF-mz4rDLlqpl55sa37zjWe-KYpXBC8JJvX7zXKntLYOlhTjZonJElfVk2JBRMNKyol4WiwwrauyIvj2rDiPcYMx5oy0z4sz0lCBG44Xxf1q3CqdkO_RGrYq2WQjukQH7fz0DlmHFFrbu_WwR-AMjFYjFUDNOdFPaY1WSeWYcgYN3t2VCcKIzBQO6ZlSLtny-jL-u3Te7GfN9Mcj7dc-pDgz_yuCyUFjd9ZMaogvimd9PuDl8bwofn75_OPqurz59nV19emm1Bw3qRSko1SwDqAznDUVVbRvhGAtr0wvasaaujesUwz3AlpGiRA9FxnUqmKMA7so3h10t8H_niAmOdqoYRiUAz9F2WCWJ9fSR0GKGWG8rjL45gG48VNwuQlJeNWQmvN2pviB0sHHGKCX22BHFfaSYDn7LDfy6LOcfZaYyOxzznt9VJ-6Ecwp62hsBt4eARW1GvqgnLbxxIm6JYLN_Xw8cJCnu7MQZNQWnAZjA-gkjbePfuXDAwU9WGdz0V-wh3jqWkYqsfw-L-W8k7jJ-1jTW_YXnGfeIw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1547165594</pqid></control><display><type>article</type><title>Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Da Villa, Giuliano ; Romanò, Luisa ; Sepe, Alessio ; Iorio, Raffaele ; Paribello, Nunzio ; Zappa, Alessandra ; Zanetti, Alessandro R</creator><creatorcontrib>Da Villa, Giuliano ; Romanò, Luisa ; Sepe, Alessio ; Iorio, Raffaele ; Paribello, Nunzio ; Zappa, Alessandra ; Zanetti, Alessandro R</creatorcontrib><description>Abstract The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing pattern of HBV infection in a former hyperendemic area (Afragola, South Italy), and to assess the long-term persistence of anti-HBs in two cohorts of individuals vaccinated as infants 18 and 23 years ago. Our data shows a significant decline in the prevalence of hepatitis B virus (HBV) markers in the general population from 1978 to 2006 (HBsAg: 13.4% versus 0.91%; anti-HBc: 66.9% versus 7.6%; p < 0.001). Data from two cohorts of vaccinees provides further evidence regarding the long-term persistence of vaccine-induced anti-HBs. Data here reported indicates that the implementation of vaccination had a great impact in the control and prevention of hepatitis B in Italy.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2007.01.044</identifier><identifier>PMID: 17280750</identifier><identifier>CODEN: VACCDE</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adolescent ; Adult ; Age ; Allergy and Immunology ; Antigens ; Applied microbiology ; Biological and medical sciences ; Carrier State - epidemiology ; Child ; Child, Preschool ; Cohort Studies ; Deoxyribonucleic acid ; DNA ; Endemic Diseases ; Female ; Females ; Fundamental and applied biological sciences. Psychology ; HBV prevalence ; Hepatitis ; Hepatitis B - epidemiology ; Hepatitis B - immunology ; Hepatitis B - prevention & control ; Hepatitis B - transmission ; Hepatitis B Antibodies - blood ; Hepatitis B e Antigens - blood ; Hepatitis B e Antigens - immunology ; Hepatitis B vaccination ; Hepatitis B Vaccines - administration & dosage ; Hepatitis B Vaccines - immunology ; Hepatitis B Vaccines - pharmacology ; Hepatitis B virus ; Hepatitis B virus - drug effects ; Hepatitis B virus - genetics ; Hepatitis B virus - isolation & purification ; Human viral diseases ; Humans ; Immunization ; Immunization, Secondary ; Infections ; Infectious diseases ; Italy - epidemiology ; Long-term protection ; Male ; Medical sciences ; Microbiology ; Miscellaneous ; Plasma ; Population ; Teenagers ; Vaccination ; Vaccines ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Viral diseases ; Viral hepatitis ; Virology</subject><ispartof>Vaccine, 2007-04, Vol.25 (16), p.3133-3136</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Limited Apr 20, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c507t-81b2283beebd53742a2f7883954df863376fd3ba30f8e932188f58374ca4335e3</citedby><cites>FETCH-LOGICAL-c507t-81b2283beebd53742a2f7883954df863376fd3ba30f8e932188f58374ca4335e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1547165594?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995,64385,64387,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18691832$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17280750$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Da Villa, Giuliano</creatorcontrib><creatorcontrib>Romanò, Luisa</creatorcontrib><creatorcontrib>Sepe, Alessio</creatorcontrib><creatorcontrib>Iorio, Raffaele</creatorcontrib><creatorcontrib>Paribello, Nunzio</creatorcontrib><creatorcontrib>Zappa, Alessandra</creatorcontrib><creatorcontrib>Zanetti, Alessandro R</creatorcontrib><title>Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Abstract The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing pattern of HBV infection in a former hyperendemic area (Afragola, South Italy), and to assess the long-term persistence of anti-HBs in two cohorts of individuals vaccinated as infants 18 and 23 years ago. Our data shows a significant decline in the prevalence of hepatitis B virus (HBV) markers in the general population from 1978 to 2006 (HBsAg: 13.4% versus 0.91%; anti-HBc: 66.9% versus 7.6%; p < 0.001). Data from two cohorts of vaccinees provides further evidence regarding the long-term persistence of vaccine-induced anti-HBs. Data here reported indicates that the implementation of vaccination had a great impact in the control and prevention of hepatitis B in Italy.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age</subject><subject>Allergy and Immunology</subject><subject>Antigens</subject><subject>Applied microbiology</subject><subject>Biological and medical sciences</subject><subject>Carrier State - epidemiology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Endemic Diseases</subject><subject>Female</subject><subject>Females</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HBV prevalence</subject><subject>Hepatitis</subject><subject>Hepatitis B - epidemiology</subject><subject>Hepatitis B - immunology</subject><subject>Hepatitis B - prevention & control</subject><subject>Hepatitis B - transmission</subject><subject>Hepatitis B Antibodies - blood</subject><subject>Hepatitis B e Antigens - blood</subject><subject>Hepatitis B e Antigens - immunology</subject><subject>Hepatitis B vaccination</subject><subject>Hepatitis B Vaccines - administration & dosage</subject><subject>Hepatitis B Vaccines - immunology</subject><subject>Hepatitis B Vaccines - pharmacology</subject><subject>Hepatitis B virus</subject><subject>Hepatitis B virus - drug effects</subject><subject>Hepatitis B virus - genetics</subject><subject>Hepatitis B virus - isolation & purification</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization, Secondary</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Italy - epidemiology</subject><subject>Long-term protection</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Plasma</subject><subject>Population</subject><subject>Teenagers</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Viral diseases</subject><subject>Viral hepatitis</subject><subject>Virology</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFks9u1DAQxiMEotvCI4AsIbhl8Z84cS4gWgFdqRIHQOrNcuxJ10tiL7azaF-mz4rDLlqpl55sa37zjWe-KYpXBC8JJvX7zXKntLYOlhTjZonJElfVk2JBRMNKyol4WiwwrauyIvj2rDiPcYMx5oy0z4sz0lCBG44Xxf1q3CqdkO_RGrYq2WQjukQH7fz0DlmHFFrbu_WwR-AMjFYjFUDNOdFPaY1WSeWYcgYN3t2VCcKIzBQO6ZlSLtny-jL-u3Te7GfN9Mcj7dc-pDgz_yuCyUFjd9ZMaogvimd9PuDl8bwofn75_OPqurz59nV19emm1Bw3qRSko1SwDqAznDUVVbRvhGAtr0wvasaaujesUwz3AlpGiRA9FxnUqmKMA7so3h10t8H_niAmOdqoYRiUAz9F2WCWJ9fSR0GKGWG8rjL45gG48VNwuQlJeNWQmvN2pviB0sHHGKCX22BHFfaSYDn7LDfy6LOcfZaYyOxzznt9VJ-6Ecwp62hsBt4eARW1GvqgnLbxxIm6JYLN_Xw8cJCnu7MQZNQWnAZjA-gkjbePfuXDAwU9WGdz0V-wh3jqWkYqsfw-L-W8k7jJ-1jTW_YXnGfeIw</recordid><startdate>20070420</startdate><enddate>20070420</enddate><creator>Da Villa, Giuliano</creator><creator>Romanò, Luisa</creator><creator>Sepe, Alessio</creator><creator>Iorio, Raffaele</creator><creator>Paribello, Nunzio</creator><creator>Zappa, Alessandra</creator><creator>Zanetti, Alessandro R</creator><general>Elsevier Ltd</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070420</creationdate><title>Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals</title><author>Da Villa, Giuliano ; Romanò, Luisa ; Sepe, Alessio ; Iorio, Raffaele ; Paribello, Nunzio ; Zappa, Alessandra ; Zanetti, Alessandro R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-81b2283beebd53742a2f7883954df863376fd3ba30f8e932188f58374ca4335e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age</topic><topic>Allergy and Immunology</topic><topic>Antigens</topic><topic>Applied microbiology</topic><topic>Biological and medical sciences</topic><topic>Carrier State - epidemiology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Endemic Diseases</topic><topic>Female</topic><topic>Females</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HBV prevalence</topic><topic>Hepatitis</topic><topic>Hepatitis B - epidemiology</topic><topic>Hepatitis B - immunology</topic><topic>Hepatitis B - prevention & control</topic><topic>Hepatitis B - transmission</topic><topic>Hepatitis B Antibodies - blood</topic><topic>Hepatitis B e Antigens - blood</topic><topic>Hepatitis B e Antigens - immunology</topic><topic>Hepatitis B vaccination</topic><topic>Hepatitis B Vaccines - administration & dosage</topic><topic>Hepatitis B Vaccines - immunology</topic><topic>Hepatitis B Vaccines - pharmacology</topic><topic>Hepatitis B virus</topic><topic>Hepatitis B virus - drug effects</topic><topic>Hepatitis B virus - genetics</topic><topic>Hepatitis B virus - isolation & purification</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization, Secondary</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Italy - epidemiology</topic><topic>Long-term protection</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Plasma</topic><topic>Population</topic><topic>Teenagers</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Viral diseases</topic><topic>Viral hepatitis</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Da Villa, Giuliano</creatorcontrib><creatorcontrib>Romanò, Luisa</creatorcontrib><creatorcontrib>Sepe, Alessio</creatorcontrib><creatorcontrib>Iorio, Raffaele</creatorcontrib><creatorcontrib>Paribello, Nunzio</creatorcontrib><creatorcontrib>Zappa, Alessandra</creatorcontrib><creatorcontrib>Zanetti, Alessandro R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Da Villa, Giuliano</au><au>Romanò, Luisa</au><au>Sepe, Alessio</au><au>Iorio, Raffaele</au><au>Paribello, Nunzio</au><au>Zappa, Alessandra</au><au>Zanetti, Alessandro R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2007-04-20</date><risdate>2007</risdate><volume>25</volume><issue>16</issue><spage>3133</spage><epage>3136</epage><pages>3133-3136</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><coden>VACCDE</coden><abstract>Abstract The aims of this study were to evaluate the impact of hepatitis B vaccination on the changing pattern of HBV infection in a former hyperendemic area (Afragola, South Italy), and to assess the long-term persistence of anti-HBs in two cohorts of individuals vaccinated as infants 18 and 23 years ago. Our data shows a significant decline in the prevalence of hepatitis B virus (HBV) markers in the general population from 1978 to 2006 (HBsAg: 13.4% versus 0.91%; anti-HBc: 66.9% versus 7.6%; p < 0.001). Data from two cohorts of vaccinees provides further evidence regarding the long-term persistence of vaccine-induced anti-HBs. Data here reported indicates that the implementation of vaccination had a great impact in the control and prevention of hepatitis B in Italy.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17280750</pmid><doi>10.1016/j.vaccine.2007.01.044</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 2007-04, Vol.25 (16), p.3133-3136 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70331992 |
| source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
| subjects | Adolescent Adult Age Allergy and Immunology Antigens Applied microbiology Biological and medical sciences Carrier State - epidemiology Child Child, Preschool Cohort Studies Deoxyribonucleic acid DNA Endemic Diseases Female Females Fundamental and applied biological sciences. Psychology HBV prevalence Hepatitis Hepatitis B - epidemiology Hepatitis B - immunology Hepatitis B - prevention & control Hepatitis B - transmission Hepatitis B Antibodies - blood Hepatitis B e Antigens - blood Hepatitis B e Antigens - immunology Hepatitis B vaccination Hepatitis B Vaccines - administration & dosage Hepatitis B Vaccines - immunology Hepatitis B Vaccines - pharmacology Hepatitis B virus Hepatitis B virus - drug effects Hepatitis B virus - genetics Hepatitis B virus - isolation & purification Human viral diseases Humans Immunization Immunization, Secondary Infections Infectious diseases Italy - epidemiology Long-term protection Male Medical sciences Microbiology Miscellaneous Plasma Population Teenagers Vaccination Vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Viral diseases Viral hepatitis Virology |
| title | Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A58%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20hepatitis%20B%20vaccination%20in%20a%20highly%20endemic%20area%20of%20south%20Italy%20and%20long-term%20duration%20of%20anti-HBs%20antibody%20in%20two%20cohorts%20of%20vaccinated%20individuals&rft.jtitle=Vaccine&rft.au=Da%20Villa,%20Giuliano&rft.date=2007-04-20&rft.volume=25&rft.issue=16&rft.spage=3133&rft.epage=3136&rft.pages=3133-3136&rft.issn=0264-410X&rft.eissn=1873-2518&rft.coden=VACCDE&rft_id=info:doi/10.1016/j.vaccine.2007.01.044&rft_dat=%3Cproquest_cross%3E20313564%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1547165594&rft_id=info:pmid/17280750&rft_els_id=1_s2_0_S0264410X0700062X&rfr_iscdi=true |